PAVmed Inc.
About PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $71.0K
- Net income
- $401.0K
- Total assets
- $38.8M
- Market cap
- $39.0M
- Gross margin
- -207.0%
- Operating margin
- -30712.7%
- Net margin
- -3477.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $71.0K
- Cost of revenue
- $218.0K
- Gross profit
- -$147.0K
- Operating expenses
- $21.7M
- Operating income
- -$21.8M
- Income tax
- $0
- Net income
- -$2.5M
- EPS (basic)
- $-5.63
- EPS (diluted)
- $-5.63
Balance sheet
- Total assets
- $38.8M
- Current assets
- $2.6M
- Total liabilities
- $16.5M
- Current liabilities
- $14.8M
- Shareholders’ equity
- $22.3M
Cash flow
- Operating cash flow
- -$5.2M
- Investing cash flow
- -$31.0K
- Financing cash flow
- $5.6M
- Net cash flow
- $353.0K
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $39.0M
- EPS (diluted)
- $-5.63
- Shares outstanding
- 7.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 28, 2016
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $401.0K in FY2025.
- Revenue grew 184% from FY2021 to FY2025.
- Gross margin of -207.0%, net margin -3477.5%.
- Trading 78% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PAVmed Inc..
Write a review
News about PAVmed Inc.
News & sentiment via Polygon.io
